Chronic Kidney Disease Therapeutics Market: Growth Opportunities, Pipeline Trends, and Future Landscape
The CKD market across the seven major markets (7MM) — the US, EU4 (Germany, France, Italy, Spain), the UK, and Japan — stood at roughly USD 5 billion in 2025, with continued growth projected through 2036. This valuation reflects the current treatment landscape, which spans erythropoietin stimulating agents, ACE inhibitors, ARBs, antidiabetic drugs, secondary hyperparathyroidism…
